Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

IONS Ionis Pharmaceuticals Inc

36,53

0,45 (1,25%)

24 Dez 2024 - Geschlossen

Verzögert um 15 Minuten

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Ionis Pharmaceuticals (NASDAQ:IONS)
Historical Stock Chart
Von Nov 2024 bis Dez 2024

Click Here for more Ionis Pharmaceuticals Charts.

Ionis Pharmaceuticals (NASDAQ:IONS)
Historical Stock Chart
Von Dez 2023 bis Dez 2024

Click Here for more Ionis Pharmaceuticals Charts.

News Ionis Pharmaceuticals Inc

Form 8-K - Current report
Freitag 20 Dezember 2024 (5 Tage vor) • Edgar (US Regulatory)

TRYNGOLZA™ (olezarsen) approved in U.S. as first-ever treatment for adults living with familial chylomicronemia syndrome as an adjunct to diet
Freitag 20 Dezember 2024 (6 Tage vor) • PR Newswire (US)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Freitag 15 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 14 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 14 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 14 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 144/A - Report of proposed sale of securities: [Amend]
Mittwoch 13 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Dienstag 12 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Dienstag 12 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Dienstag 12 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Freitag 8 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Ionis to present at upcoming investor conferences
Donnerstag 7 November 2024 (2 Monate vor) • PR Newswire (US)

Weitere Ionis Pharmaceuticals Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen